| NDC包装代码 | 产品NDC | 产品类型 | 商品名 | 通用名 | 剂型 | 给药途径 | 上市日期 | 结束日期 | 市场类别 | 申请号 | 标签持有者 | 活性成分 | 规格 | 包装描述 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 0169-3003-15 | 0169-3003 | HUMAN OTC DRUG | Novolin R | Human Insulin | INJECTION, SOLUTION | SUBCUTANEOUS | 20190906 | N/A | BLA | BLA019938 | Novo Nordisk | INSULIN HUMAN | 100 [iU]/mL | 5 SYRINGE, PLASTIC in 1 CARTON (0169-3003-15) / 3 mL in 1 SYRINGE, PLASTIC (0169-3003-01) |
| 0169-3003-25 | 0169-3003 | HUMAN OTC DRUG | Novolin R | Human Insulin | INJECTION, SOLUTION | SUBCUTANEOUS | 20190906 | N/A | BLA | BLA019938 | Novo Nordisk | INSULIN HUMAN | 100 [iU]/mL | 5 SYRINGE, PLASTIC in 1 CARTON (0169-3003-25) / 3 mL in 1 SYRINGE, PLASTIC (0169-3003-12) |
| 0169-1833-02 | 0169-1833 | HUMAN OTC DRUG | Novolin R | Human Insulin | INJECTION, SOLUTION | SUBCUTANEOUS | 19910625 | N/A | BLA | BLA019938 | Novo Nordisk | INSULIN HUMAN | 100 [iU]/mL | 1 VIAL in 1 CARTON (0169-1833-02) / 10 mL in 1 VIAL |
| 0169-1833-11 | 0169-1833 | HUMAN OTC DRUG | Novolin R | Human Insulin | INJECTION, SOLUTION | SUBCUTANEOUS | 19910625 | N/A | BLA | BLA019938 | Novo Nordisk | INSULIN HUMAN | 100 [iU]/mL | 1 VIAL in 1 CARTON (0169-1833-11) / 10 mL in 1 VIAL |